Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 2/20 | 0.47 |
| ▸ | RXRB | P28702 | 2/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | ENPP3 | O14638 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14999152 | 0.95 | RXRA (0.42) | RXRARXRBCNR2SCN5ANPC1 | |
| SCHEMBL14553136 | 0.85 | ESR1 (0.41) | SCN5ANPC1RAB9ANR1H2NR1H3 | |
| SCHEMBL13664879 | 0.82 | ENPP3 (0.45) | SCN5ANPC1RAB9ANR1H2NR1H3 | |
| SCHEMBL12367284 | 0.82 | ENPP3 (0.45) | SCN5ANPC1RAB9ANR1H2NR1H3 | |
| SCHEMBL10997473 | 0.82 | NR1H2 (0.44) | SCN5ANR1H2NR1H3ALDH1A1ENPP3 | |
| SCHEMBL28308652 | 0.82 | NR1H2 (0.44) | SCN5ANR1H2NR1H3ALDH1A1ENPP3 | |
| SCHEMBL20022141 | 0.81 | ENPP3 (0.51) | NPC1RAB9ANOTUMALDH1A1ENPP3 | |
| SCHEMBL16802048 | 0.80 | ENPP3 (0.54) | NPC1RAB9ANOTUMALDH1A1ENPP3 | |
| SCHEMBL12816149 | 0.79 | RXRA (0.45) | RXRARXRBCNR2NPC1RAB9A | |
| SCHEMBL25763105 | 0.79 | SCN5A (0.35) | SCN5ARAB9ANR1H2NR1H3NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3105202-B1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2024-11-13 | — | — | EP | disclosed |
| CN-106103392-B | Graphene nanoribbons with controlled zig-zag edge and curved edge configurations | 巴斯夫欧洲公司 | 2020-06-26 | — | — | CN | disclosed |
| US-10329378-B2 | Graphene nanoribbons with controlled zig-zag edge and cove edge configuration | BASF SE (DE) | 2019-06-25 | — | — | US | disclosed |
| US-10329378-B2 | Graphene nanoribbons with controlled zig-zag edge and cove edge configuration | BASF SE (DE) | 2019-06-25 | — | — | US | disclosed |
| US-20170051101-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2017-02-23 | — | — | US | disclosed |
| US-20170051101-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2017-02-23 | — | — | US | disclosed |
| US-20170051101-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2017-02-23 | — | — | US | disclosed |
| EP-3105202-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2016-12-21 | — | — | EP | disclosed |
| WO-2015121785-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2015-08-20 | — | — | WO | disclosed |
| WO-2015121785-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | BASF SE (DE) | 2015-08-20 | — | — | WO | disclosed |
| EP-2907791-A1 | Graphene nanoribbons with controlled zig-zag edge and cove edge configuration | BASF SE (DE) | 2015-08-19 | — | — | EP | disclosed |
| EP-2907791-A1 | Graphene nanoribbons with controlled zig-zag edge and cove edge configuration | BASF SE (DE) | 2015-08-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170051101-A1 | GRAPHENE NANORIBBONS WITH CONTROLLED ZIG-ZAG EDGE AND COVE EDGE CONFIGURATION | ZC3HAV1L, ZC3HAV1, ZYX | RXRA 2776/4885RXRB 2503/4885CNR2 4494/4885 |
| US-10329378-B2 | Graphene nanoribbons with controlled zig-zag edge and cove edge configuration | ZC3HAV1L, ZC3HAV1, ZYX | RXRA 2776/4885RXRB 2503/4885CNR2 4494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.